Today: 21 May 2026
Browse Category

NASDAQ:ISRG 17 January 2026 - 12 May 2026

Intuitive Surgical Stock Drops 6%: Why ISRG Hit A Fresh 52-Week Low Today

Intuitive Surgical Stock Drops 6%: Why ISRG Hit A Fresh 52-Week Low Today

Intuitive Surgical shares dropped 6.6% Monday to $417.80, hitting a 12-month low after the FDA classified a recall of its SureForm stapler reloads as the most serious type, citing four injuries and one death. The company reported first-quarter revenue up 23% to $2.77 billion, but warned tariffs and safety issues could affect 2026 results. Johnson & Johnson advanced its rival OTTAVA robot in a key gastric-bypass study.
11 May 2026
·
Intuitive Surgical Stock Rebounds As Da Vinci Robot Demand Gives ISRG Bulls A Fresh Test

Intuitive Surgical Stock Rebounds As Da Vinci Robot Demand Gives ISRG Bulls A Fresh Test

Intuitive Surgical shares climbed to $482.22 on April 24 after the company raised its 2026 growth outlook and reported a 23% jump in first-quarter revenue to $2.77 billion. The firm placed 431 da Vinci systems in the quarter and now expects 2026 procedure growth of 13.5% to 15.5%. U.S. bariatric procedures fell 10%, while China and Japan saw slower growth. Competition from Johnson & Johnson and Medtronic is increasing.
25 April 2026
··
Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical stock (ISRG) ends week lower as insider trades surface; what to watch next

Intuitive Surgical shares fell 0.66% to $504.22 Friday, extending a two-day slide after a 2.78% drop Thursday. EVP Myriam Curet sold 126 shares at $520.02 each under a preset plan, while CEO David Rosa received performance stock units set to vest in 2026 and 2027. The company forecasts 2026 procedure growth of 13%-15% and a 67%-68% non-GAAP gross margin, factoring in a 1.2% tariff hit. Markets reopen Monday.
1 February 2026
ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

ISRG stock slips after FDA clears da Vinci 5 for heart procedures; TD Cowen starts at Buy

Intuitive Surgical shares fell 0.7% to $525.09 Tuesday after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The S&P 500 ETF rose 0.5% and QQQ gained 0.9%. TD Cowen initiated coverage with a Buy rating and $660 target, citing potential for expanded hospital adoption. Intuitive forecasts 13–15% da Vinci procedure growth in 2026, with a 1.2% revenue hit from tariffs.
27 January 2026
····
ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

ISRG stock edges up after Intuitive Surgical wins FDA clearance for da Vinci 5 heart procedures

Intuitive Surgical shares rose about 1% after the FDA cleared its da Vinci 5 robot for select cardiac procedures. The company plans a limited U.S. rollout through 2026. The clearance follows last week’s warning of slower global procedure growth, with forecasts now at 13% to 15% for 2026. Investors are weighing the new approval against concerns over hospital budgets and rising competition.
26 January 2026
··
Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock price: what to watch Monday after ISRG’s 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares closed at $523.99 Friday, down 0.4% after the company forecast da Vinci procedure growth of 13%–15% by 2026 and warned tariffs could pressure margins. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted earnings of $2.53 per share. The company reported over 20 million da Vinci procedures worldwide. FDA cleared new cardiac uses for its da Vinci 5 robot.
25 January 2026
··
Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical stock slips into weekend after earnings beat, with tariffs and 2026 outlook in focus

Intuitive Surgical shares closed Friday at $523.99, down 0.4%, after the company beat quarterly estimates but projected slower da Vinci procedure growth and flagged higher tariff costs for 2026. The firm reported Q4 revenue of $2.87 billion and installed 532 da Vinci systems. U.S. markets remain closed until Monday. Investors focused on tariffs and hospital demand signals heading into next week.
25 January 2026
··
Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical stock price dips as 2026 da Vinci outlook cools after Q4 beat (ISRG)

Intuitive Surgical shares fell 0.2% to $524.65 after the company forecast slower da Vinci procedure growth of 13–15% for 2026, down from 18% in 2025. Fourth-quarter revenue rose 19% to $2.87 billion, with adjusted profit topping estimates. Management cited tariff risks and rising competition as headwinds. The company installed 532 da Vinci systems in Q4, bringing its total to 11,106.
23 January 2026
··
Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
23 January 2026
··
Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical stock whipsaws after Q4 beat as 2026 da Vinci outlook and tariffs hit focus

Intuitive Surgical shares rose 0.4% to $525.81 in after-hours trading Thursday after quarterly earnings beat forecasts. The company reported a 19% revenue increase to $2.87 billion, with da Vinci procedures up 17%. Intuitive projects 13%-15% da Vinci procedure growth in 2026 but warned tariffs could cut margins. Investors remain focused on procedure growth and tariff impacts ahead of Friday’s session.
23 January 2026
···
Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical Q4 2025 earnings beat lifts ISRG, but 2026 da Vinci forecast slows on tariffs

Intuitive Surgical reported Q4 revenue up 19% to $2.87 billion and adjusted earnings of $2.53 per share, beating analyst estimates. Shares rose about 3% in after-hours trading. The company forecast 13% to 15% growth in da Vinci procedures for 2026, slower than 2025, and warned tariffs may pressure margins. Intuitive installed 532 da Vinci systems in the quarter, ending 2025 with 11,106 in use.
22 January 2026
··
Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical stock ticks up ahead of earnings after a bruising slide — what traders watch next

Intuitive Surgical shares rose 0.9% to $528.38 Thursday ahead of fourth-quarter earnings, after a recent slide left the stock 14% below its 52-week high. Investors are focused on growth in da Vinci procedures for 2026 after last week’s cautious outlook. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year over year. Results and management commentary are due after the bell.
22 January 2026
··
Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical stock slips as ISRG heads into key earnings call after softer 2026 outlook

Intuitive Surgical shares fell 1.5% to $526.76 Tuesday afternoon, mirroring broader U.S. market declines. The company is set to report earnings Jan. 22 after signaling da Vinci procedure growth of 13%–15% in 2026 and preliminary Q4 revenue near $2.87 billion. Investors remain focused on procedure outlook and competition from Medtronic and Johnson & Johnson.
20 January 2026
··
Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Why Intuitive Surgical stock price is in focus: ISRG heads into earnings week after Friday dip

Intuitive Surgical closed down 1.2% at $535 on Friday after forecasting 2026 da Vinci procedure growth of 13%–15%, below analyst expectations. Preliminary Q4 revenue was $2.87 billion, up 19% year over year, with 532 da Vinci systems placed. U.S. markets will reopen Tuesday after the Martin Luther King Jr. Day holiday. Shares may react further after the company’s Jan. 22 results.
19 January 2026
··
Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical stock (ISRG) heads into earnings week after Friday drop — what to watch next

Intuitive Surgical shares fell 1.2% to $535 on Friday, marking five straight sessions of losses as trading volume rose. The company reported preliminary Q4 revenue of $2.87 billion, up 19% year-over-year, and a 17% increase in da Vinci procedures. CEO Dave Rosa said da Vinci 5 usage is 11% higher than the Xi model. Full Q4 results are due Jan. 22.
17 January 2026
··
1 2 3

Stock Market Today

  • Sensex nudges up as oil prices drop and rupee strengthens
    May 21, 2026, 3:46 AM EDT. Indian shares edged higher on Thursday, with the BSE Sensex up 0.20% and the Nifty 50 gaining 0.30%. The rise followed a decline in Brent crude oil prices, which dipped 5.6% near $106 a barrel, and a rebound in the rupee supported by Reserve Bank of India dollar sales. Despite early gains fading, investor sentiment improved amid easing inflation pressures and stabilizing currency. Key earnings influenced moves, with Apollo Hospitals posting a 36% profit increase and Lenskart Solutions reporting 46% revenue growth. Caution persisted over Ola Electric due to a 5% revenue decline. Market momentum depends on crude oil trends and rupee stability as investors balance earnings strength against macroeconomic challenges like high U.S. bond yields.

Latest articles

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

Fed Officials Float Rate Hikes Again as Cut Hopes Wobble

21 May 2026
Federal Reserve minutes released Wednesday showed most officials see possible rate hikes if inflation remains above 2%. Markets and economists have pushed back expectations for rate cuts, with some now anticipating increases. The Fed’s benchmark rate held at 3.50% to 3.75% in April. The next FOMC meeting is set for June 16-17.
Treasury yields close in on 2007 highs, Wall Street takes note

Treasury yields close in on 2007 highs, Wall Street takes note

21 May 2026
The 30-year U.S. Treasury yield reached 5.128% early Thursday, near its highest level since 2007, with the 10-year at 4.593%. Treasury data showed the 30-year par yield at 5.11% Wednesday, down from 5.18% Tuesday. The average 30-year fixed U.S. mortgage rate rose to 6.56%, the highest in seven weeks, as mortgage applications fell 2.3%. Fed minutes showed most policymakers see more tightening if inflation stays above 2%.
Asia Chips Rally Lifts Nvidia, Samsung Shares

Asia Chips Rally Lifts Nvidia, Samsung Shares

21 May 2026
Asian stocks jumped Thursday, led by chipmakers after Nvidia forecast stronger revenue and Samsung Electronics reached a deal to avert a strike. MSCI’s Asia-Pacific index outside Japan rose 2.6%, with South Korea’s KOSPI up over 7% and Samsung shares nearly 8% higher. SK Hynix surged 11.3%. Japan’s exports climbed 14.8% in April, but its services PMI fell to 50.0, ending more than a year of growth.
Go toTop